Alpha 2.0
Login Register
» Articles » PMID: 14174811

[PROLIFERATIVE EFFECT OF 17-ALPHA-ETHINYL-19-NORTESTOSTERONE]

Overview
Journal Arch Gynakol
Specialty Gynecology & Obstetrics
Date 1964 Feb 4
PMID 14174811
Citations 1
Authors
M Henzl
J JIRASEK
J Horsky
J Presl
Affiliations
Soon will be listed here.
Citing Articles

The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.

Stepan J, Pospichal J, Schreiber V, Kanka J, MENSIK J, Presl J Calcif Tissue Int. 1989; 45(5):273-80.

PMID: 2509014 DOI: 10.1007/BF02556018.

References
1.
Kaiser R . [Progestative effect of 19-nortestosterone compounds by oral administration]. Geburtshilfe Frauenheilkd. 1957; 17(1):24-37. View
2.
Breuer H, DARDENNE U, NOCKE W . [Excretion of 17-ketosteroids, 17-ketogenic steroids and estrogens in man after the administration of 17 alpha-ethynyl-19-nortestosterone esters]. Acta Endocrinol (Copenh). 1960; 33:10-26. View
3.
PAULSEN C, Leach R, LANMAN J, GOLDSTON N, MADDOCK W, HELLER C . Inherent estrogenicity of norethindrone and norethynodrel: comparison with other synthetic progestins and progesterone. J Clin Endocrinol Metab. 1962; 22:1033-9. DOI: 10.1210/jcem-22-10-1033. View
4.
Chang M, Hafez E, MERRILL A, PINCUS G, ZARROW M . Studies of the biological activity of certain 19-nor steroids in female animals. Endocrinology. 1956; 59(6):695-707. DOI: 10.1210/endo-59-6-695. View
5.
Kaiser R . [On the increase of urinary estrogens following administration of 19-nortestosterone]. Dtsch Med Wochenschr. 1960; 85:1457-60. DOI: 10.1055/s-0028-1112602. View